Investigating the Question: Why Was Chymopapain Discontinued?
•
2 min read
Anaphylaxis, a severe allergic reaction, occurred in up to 1% of patients treated with chymopapain, contributing to a complex debate about its safety. This article explores the full story of why was chymopapain discontinued despite its effectiveness for many.
